Global Glioma Treatment market size is expected to reach $7.44 billion by 2030 at 6.8%, glioma treatment market driven by the surge in demand for personalized medicine
Read MoreThe glioblastoma multiforme treatment market is projected to reach $4.46 billion by 2030, growing at 10.2% CAGR, driven by targeted therapies, immunotherapy, and precision medicine adoption.
Read MoreGlobal Non-Proliferative Diabetic Retinopathy market size is expected to reach $3.96.8 billion by 2030 at 6.8%, segmented as by anti-vascular endothelial growth factor (vegf) therapy, bevacizumab (avastin), ranibizumab (lucentis), aflibercept (eylea)
Read MoreGlobal Glioblastoma Multiforme market size is expected to reach $3.94 billion by 2030 at 7.8%, impact of rising brain disorder cases on the market growth
Read MoreGlobal Non-Muscle Invasive Bladder Cancer market size is expected to reach $4.82 billion by 2030 at 5.6%, the growing demand for minimally invasive procedures driving the market
Read MoreGlobal Glaucoma market size is expected to reach $10.62 billion by 2030 at 5.3%, impact of rising chronic eye conditions on vision loss and treatment demand
Read MoreGlobal Non-invasive Prenatal Testing market size is expected to reach $12.37 billion by 2030 at 14.4%, elevated down syndrome incidence and maternal age is fueling growth in non-invasive prenatal testing market
Read MoreGlobal Gingivitis market size is expected to reach $9.3 Billion by 2030 at 4.5%, increasing prevalence of gum disease fueling the growth of the market due to rising cases and unhealthy lifestyle factors
Read MoreGlobal Non-Insulin Therapies For Diabetes market size is expected to reach $28.39 billion by 2030 at 5.9%, segmented as analogs, exenatide, liraglutide, dulaglutide, semaglutide_x000D_
7) by sodium-glucose co-transporter-2 (sglt
Global Gingival Recession market size is expected to reach $4.42 Billion by 2030 at 6%, increasing awareness of oral health fueling the growth of the market due to rising focus on prevention and treatment of dental issues
Read More